+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

mRNA Transfection Reagent Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6153813
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mRNA Transfection Reagent Market is projected to reach USD 1.35 Billion in 2026. It is expected to continue growing at a CAGR of 10.97%, reaching USD 2.52 Billion by 2032.

mRNA Transfection Reagents: Executive Overview

mRNA transfection reagents enable the delivery of messenger RNA into cells for research, discovery, and therapeutic development. Demand is shaped by advances in cell and gene therapy, vaccine research, protein expression, functional genomics, and increasingly complex ex vivo cell-engineering workflows. Product performance is typically assessed through delivery efficiency, cell viability, reproducibility, cargo compatibility, scalability, and ease of use across cell types and experimental formats.

How Cell Engineering Is Reshaping Reagent Requirements

The field is moving from relatively standardized research protocols toward applications involving primary cells, stem cells, immune cells, organoids, and other difficult-to-transfect systems. This shift increases the importance of low-toxicity formulations, consistent lot performance, workflow automation, and compatibility with chemically modified or structurally optimized mRNA. Translational programs are also placing greater emphasis on traceability, process control, and methods that can be adapted from small-scale experiments to controlled manufacturing environments.

Artificial Intelligence Accelerates Design, Screening, and Optimization

Artificial intelligence is contributing to mRNA transfection workflows by helping researchers prioritize lipid and polymer formulations, analyze experimental variables, and identify relationships between delivery conditions and cellular outcomes. Machine-learning tools can support image analysis, assay interpretation, and design-of-experiments planning, while automation can improve repeatability in formulation screening. These benefits depend on high-quality training data, standardized assays, transparent validation, and careful control of model bias; AI complements rather than replaces laboratory verification.

Regional Dynamics Across Research and Biomanufacturing Hubs

North America combines strong biomedical research capacity with substantial activity in cell therapy, vaccine development, and translational biotechnology. Europe benefits from established academic networks, coordinated regulatory frameworks, and advanced bioprocessing capabilities. Asia-Pacific is supported by expanding pharmaceutical, biotechnology, and life-science infrastructure, particularly in China, Japan, South Korea, Australia, and India. Latin America is developing research and production capacity around universities, public-health institutions, and biopharmaceutical partnerships. The Middle East is investing in life-science capability and specialized research infrastructure, while Africa’s opportunity is linked to strengthening laboratory networks, local manufacturing, and access to enabling technologies.

Multilateral Groups Shape Standards, Investment, and Access

ASEAN cooperation can support regional research connectivity, supply-chain development, and technology transfer across diverse markets. BRICS members bring significant scientific, manufacturing, and public-health capabilities, although regulatory and infrastructure conditions vary. The European Union benefits from cross-border research programs and harmonized regulatory processes. G7 economies influence advanced biomedical research, quality expectations, and supply-chain resilience. GCC countries are building research and healthcare capacity through strategic investment, while NATO members contribute substantial scientific and industrial capabilities relevant to biotechnology readiness. Across these groups, interoperability, workforce development, and dependable access to critical laboratory inputs remain important priorities.

Country-Level Priorities in mRNA Delivery Research

The United States and Canada maintain broad research ecosystems spanning biomedical institutions, biotechnology, and advanced cell-engineering applications. China is expanding domestic life-science capabilities, while Japan and South Korea emphasize high-quality translational research and advanced manufacturing. Australia supports strong academic and clinical research networks, and India is building capacity in biotechnology, vaccine science, and scalable laboratory operations. In Europe, Germany, France, Italy, Spain, and the United Kingdom combine university research, pharmaceutical development, and regulatory expertise, with differing national funding and procurement structures. Brazil and Mexico are strengthening regional research and production capabilities. Russia retains scientific capacity but faces constraints linked to international access, collaboration, and supply continuity.

Priorities for Improving Performance, Resilience, and Adoption

Industry leaders should validate reagents across relevant cell models rather than relying on a single benchmark system, and should measure delivery efficiency alongside viability, phenotype preservation, and downstream function. Portfolio planning should include formulations for difficult-to-transfect cells, modified mRNA, and automated workflows. Organizations should qualify multiple supply routes where feasible, strengthen cold-chain and quality documentation, and establish clear comparability protocols when changing materials. Partnerships with academic laboratories, contract research organizations, and manufacturing specialists can shorten optimization cycles, while responsible AI deployment should include curated datasets, human oversight, and experimentally confirmed results.

Methodology for a Data-Grounded Executive Assessment

This executive summary uses the defined mRNA transfection reagent category and synthesizes qualitative evidence from established application areas, technology characteristics, research practices, regulatory considerations, and geographic biotechnology conditions. The assessment compares regional, group, and country contexts using indicators such as research infrastructure, cell and gene therapy activity, biomanufacturing capability, technology adoption, and supply-chain requirements. It intentionally excludes market estimates, market shares, forecasts, and company-specific claims. Conclusions are framed as evidence-based strategic themes rather than numerical market projections.

Strategic Outlook for mRNA Transfection Reagents

mRNA transfection reagents are becoming more important as biological research advances toward precise, transient, and programmable cell manipulation. The strongest opportunities are associated with difficult cell types, reproducible translational workflows, automation, and better integration of formulation science with data analytics. Progress will depend on robust validation, regulatory-aware development, resilient sourcing, and regional investment in skilled personnel and laboratory infrastructure. Leaders that align product performance with practical workflow needs will be better positioned to support the next generation of mRNA-enabled research and therapeutic development.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. mRNA Transfection Reagent Market, by Product Type
7.1. Introduction
7.2. Calcium Phosphate
7.3. Electroporation System
7.4. Lipid Based Reagent
7.5. Polymer Based Reagent
8. mRNA Transfection Reagent Market, by Application
8.1. Introduction
8.2. Ex Vivo
8.3. In Vivo
9. mRNA Transfection Reagent Market, by End User
9.1. Introduction
9.2. Academic Research Institutes
9.2.1. Government Research Centers
9.2.2. University Labs
9.3. Contract Research Organizations
9.3.1. Clinical CROS
9.3.2. Discovery CROS
9.4. Pharmaceutical Biotechnology
9.4.1. Big Pharma
9.4.2. Small Biotech
10. mRNA Transfection Reagent Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. mRNA Transfection Reagent Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. mRNA Transfection Reagent Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. AAT Bioquest, Inc.
14.2. Altogen Biosystems LLC
14.3. Beijing TransGen Biotech Co., Ltd.
14.4. Bio-Techne Corporation
14.5. Biogenuix Medsystems Pvt. Ltd.
14.6. Biontex Laboratories GmbH
14.7. Creative Biolabs Inc.
14.8. GenScript Biotech Corporation
14.9. Lonza Group AG
14.10. MaxCyte, Inc.
14.11. Merck KGaA
14.12. Miltenyi Biotec B.V. & Co. KG
14.13. Mirus Bio LLC
14.14. MyBioSource, Inc.
14.15. OriGene Technologies, Inc.
14.16. OZ Biosciences SAS
14.17. Polyplus-transfection SA
14.18. Promega Corporation
14.19. QIAGEN N.V.
14.20. RJH Biosciences Inc.
14.21. Sartorius AG
14.22. Sopachem NV
14.23. Stemcell Technologies Inc.
14.24. Takara Bio Inc.
14.25. Thermo Fisher Scientific Inc.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global mRNA Transfection Reagent Market, Years Considered for the Study
FIGURE 2. Global mRNA Transfection Reagent Market, Research Design
FIGURE 3. Global mRNA Transfection Reagent Market, Research Framework
FIGURE 4. Global mRNA Transfection Reagent Market, Data Triangulation
FIGURE 5. Global mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
FIGURE 6. Global mRNA Transfection Reagent Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global mRNA Transfection Reagent Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global mRNA Transfection Reagent Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global mRNA Transfection Reagent Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global mRNA Transfection Reagent Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global mRNA Transfection Reagent Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global mRNA Transfection Reagent Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global mRNA Transfection Reagent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global mRNA Transfection Reagent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global mRNA Transfection Reagent Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global mRNA Transfection Reagent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global mRNA Transfection Reagent Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global mRNA Transfection Reagent Market Segmentation & Coverage
TABLE 2. Global mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 3. Global mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Calcium Phosphate Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Calcium Phosphate Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Calcium Phosphate Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Electroporation System Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Electroporation System Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Electroporation System Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Lipid Based Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Lipid Based Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Lipid Based Reagent Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Polymer Based Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Polymer Based Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Polymer Based Reagent Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 17. Global Ex Vivo Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Ex Vivo Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Ex Vivo Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global In Vivo Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global In Vivo Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global In Vivo Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 24. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Government Research Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Government Research Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Government Research Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global University Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global University Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global University Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Clinical CROS Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Clinical CROS Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Clinical CROS Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Discovery CROS Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Discovery CROS Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Discovery CROS Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Pharmaceutical Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Pharmaceutical Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Pharmaceutical Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Big Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Big Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Big Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Small Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Small Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Small Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global mRNA Transfection Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific mRNA Transfection Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 59. North America mRNA Transfection Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. North America mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 61. North America mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 62. North America mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 63. North America mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 64. North America mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 65. North America mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 66. Latin America mRNA Transfection Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Latin America mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. Latin America mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. Latin America mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 70. Latin America mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 71. Latin America mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 72. Latin America mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 73. Europe mRNA Transfection Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Europe mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 75. Europe mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Europe mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Europe mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 78. Europe mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 79. Europe mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 80. Middle East mRNA Transfection Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Middle East mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 82. Middle East mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Middle East mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Middle East mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 85. Middle East mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 86. Middle East mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 87. Africa mRNA Transfection Reagent Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Africa mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. Africa mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. Africa mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Africa mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 92. Africa mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 93. Africa mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 94. Global mRNA Transfection Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. ASEAN mRNA Transfection Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. ASEAN mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. ASEAN mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. ASEAN mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. ASEAN mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 100. ASEAN mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 101. ASEAN mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 102. GCC mRNA Transfection Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. GCC mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. GCC mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. GCC mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. GCC mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 107. GCC mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 108. GCC mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 109. European Union mRNA Transfection Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. European Union mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. European Union mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. European Union mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. European Union mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 114. European Union mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 115. European Union mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 116. BRICS mRNA Transfection Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. BRICS mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. BRICS mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. BRICS mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. BRICS mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 121. BRICS mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 122. BRICS mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 123. G7 mRNA Transfection Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. G7 mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. G7 mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. G7 mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. G7 mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 128. G7 mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 129. G7 mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 130. NATO mRNA Transfection Reagent Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. NATO mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. NATO mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. NATO mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. NATO mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 135. NATO mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 136. NATO mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 137. Global mRNA Transfection Reagent Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. United States mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 139. United States mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. United States mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. United States mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. United States mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 143. United States mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 144. United States mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 145. Canada mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 146. Canada mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. Canada mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. Canada mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Canada mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 150. Canada mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 151. Canada mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 152. Mexico mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 153. Mexico mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. Mexico mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Mexico mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. Mexico mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 157. Mexico mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 158. Mexico mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 159. Brazil mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 160. Brazil mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. Brazil mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Brazil mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Brazil mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 164. Brazil mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 165. Brazil mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 166. United Kingdom mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 167. United Kingdom mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. United Kingdom mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. United Kingdom mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. United Kingdom mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 171. United Kingdom mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 172. United Kingdom mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 173. Germany mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 174. Germany mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. Germany mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Germany mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Germany mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 178. Germany mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 179. Germany mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 180. France mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 181. France mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. France mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. France mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. France mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 185. France mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 186. France mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 187. Russia mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 188. Russia mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. Russia mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Russia mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Russia mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 192. Russia mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 193. Russia mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 194. Italy mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 195. Italy mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. Italy mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Italy mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Italy mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 199. Italy mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 200. Italy mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 201. Spain mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 202. Spain mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Spain mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Spain mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Spain mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 206. Spain mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 207. Spain mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 208. China mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 209. China mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. China mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. China mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. China mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 213. China mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 214. China mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 215. India mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 216. India mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. India mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. India mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. India mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 220. India mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 221. India mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 222. Japan mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 223. Japan mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. Japan mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Japan mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Japan mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 227. Japan mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 228. Japan mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 229. Australia mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 230. Australia mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. Australia mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. Australia mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Australia mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 234. Australia mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 235. Australia mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 236. South Korea mRNA Transfection Reagent Market Size, 2017-2032 (USD Million)
TABLE 237. South Korea mRNA Transfection Reagent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. South Korea mRNA Transfection Reagent Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. South Korea mRNA Transfection Reagent Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. South Korea mRNA Transfection Reagent Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 241. South Korea mRNA Transfection Reagent Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 242. South Korea mRNA Transfection Reagent Market Size, by Pharmaceutical Biotechnology, 2017-2032 (USD Million)
TABLE 243. Global mRNA Transfection Reagent Market Share, by Key Player, 2025
TABLE 244. Global mRNA Transfection Reagent Market, Key Experts

Companies Mentioned

  • AAT Bioquest, Inc.
  • Altogen Biosystems LLC
  • Beijing TransGen Biotech Co., Ltd.
  • Bio-Techne Corporation
  • Biogenuix Medsystems Pvt. Ltd.
  • Biontex Laboratories GmbH
  • Creative Biolabs Inc.
  • GenScript Biotech Corporation
  • Lonza Group AG
  • MaxCyte, Inc.
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Mirus Bio LLC
  • MyBioSource, Inc.
  • OriGene Technologies, Inc.
  • OZ Biosciences SAS
  • Polyplus-transfection SA
  • Promega Corporation
  • QIAGEN N.V.
  • RJH Biosciences Inc.
  • Sartorius AG
  • Sopachem NV
  • Stemcell Technologies Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.